Author

Alaina D. Oltmans

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5117723148

A phase II study of pemetrexed and pembrolizumab in patients (pts) with recurrent and/or metastatic (R/M) salivary gland cancer (SGC): Results from non-adenoid cystic cohort.

2025 · Katharine Andress Rowe Price, Nathan R. Foster, et al. · Journal of Clinical Oncology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: